ID: ALA3357629

Max Phase: Preclinical

Molecular Formula: C22H24BrN3O4

Molecular Weight: 474.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](OC(=O)N1CCC[C@H]1C(=O)NC[C@@H]1CC(Br)=NO1)c1ccc2ccccc2c1

Standard InChI:  InChI=1S/C22H24BrN3O4/c1-14(16-9-8-15-5-2-3-6-17(15)11-16)29-22(28)26-10-4-7-19(26)21(27)24-13-18-12-20(23)25-30-18/h2-3,5-6,8-9,11,14,18-19H,4,7,10,12-13H2,1H3,(H,24,27)/t14-,18-,19-/m0/s1

Standard InChI Key:  MZTUFMTZBFIKDQ-JVPBZIDWSA-N

Associated Targets(Human)

Protein-glutamine gamma-glutamyltransferase K 164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-glutamine gamma-glutamyltransferase 1221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 474.36Molecular Weight (Monoisotopic): 473.0950AlogP: 4.12#Rotatable Bonds: 5
Polar Surface Area: 80.23Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.35CX LogD: 3.35
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.71Np Likeness Score: -0.91

References

1. Klöck C, Herrera Z, Albertelli M, Khosla C..  (2014)  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.,  57  (21): [PMID:25333388] [10.1021/jm501145a]

Source